Healthcare provider profile · identity verified

Jeff D. Tracy, MD

Family Practice · ANAHEIM, CA · NPI 1023189073

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	784	256
Amlodipine Besylate	Amlodipine Besylate	513	162
Rosuvastatin Calcium	Rosuvastatin Calcium	451	154
Levothyroxine Sodium	Levothyroxine Sodium	382	100
Losartan Potassium	Losartan Potassium	285	102
Omeprazole	Omeprazole	260	115
Lisinopril	Lisinopril	240	74
Meloxicam	Meloxicam	229	98
Trazodone Hcl	Trazodone Hcl	223	67
Tamsulosin Hcl	Tamsulosin Hcl	210	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	60
Metformin Hcl	Metformin Hcl	164	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	160	52
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	157	52
Gabapentin	Gabapentin	155	45
Metoprolol Tartrate	Metoprolol Tartrate	148	54
Albuterol Sulfate Hfa	Albuterol Sulfate	145	68
Simvastatin	Simvastatin	144	44
Finasteride	Finasteride	131	37
Metformin Hcl Er	Metformin Hcl	125	53
Alendronate Sodium	Alendronate Sodium	121	35
Atenolol	Atenolol	120	34
Sertraline Hcl	Sertraline Hcl	101	43
Pantoprazole Sodium	Pantoprazole Sodium	97	34
Potassium Chloride	Potassium Chloride	87	30
Terazosin Hcl	Terazosin Hcl	86	27
Lorazepam	Lorazepam	75	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	13
Allopurinol	Allopurinol	72	25
Prednisone	Prednisone	72	52
Lactulose	Lactulose	70	11
Pradaxa	Dabigatran Etexilate Mesylate	68	26
Sumatriptan Succinate	Sumatriptan Succinate	65	13
Fluoxetine Hcl	Fluoxetine Hcl	61	20
Furosemide	Furosemide	61	22
Jardiance	Empagliflozin	55	18
Temazepam	Temazepam	55	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	14
Hydrochlorothiazide	Hydrochlorothiazide	50	17
Doxycycline Monohydrate	Doxycycline Monohydrate	49	44
Triamcinolone Acetonide	Triamcinolone Acetonide	49	34
Valacyclovir	Valacyclovir Hcl	48	21
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	46	46
Clonazepam	Clonazepam	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	41
Bupropion Hcl Sr	Bupropion Hcl	44	15
Glipizide	Glipizide	43	17
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	41	41
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	11
Alprazolam	Alprazolam	38	18
Estradiol	Estradiol	38	13
Azelastine Hcl	Azelastine Hcl	36	15
Ibuprofen	Ibuprofen	35	16
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Alvesco	Ciclesonide	33	19
Azithromycin	Azithromycin	33	29
Metoprolol Succinate	Metoprolol Succinate	33	12
Carvedilol	Carvedilol	32	12
Fluticasone Propionate	Fluticasone Propionate	32	11
Citalopram Hbr	Citalopram Hydrobromide	31	11
Bisoprolol Fumarate	Bisoprolol Fumarate	30	suppressed
Eliquis	Apixaban	30	suppressed
Ketoconazole	Ketoconazole	30	15
Breyna	Budesonide/Formoterol Fumarate	29	13
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	29	29
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Acyclovir	Acyclovir	26	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	21
Cephalexin	Cephalexin	25	19
Tadalafil	Tadalafil	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	11
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Mupirocin	Mupirocin	24	18
Naproxen	Naproxen	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	22
Rizatriptan	Rizatriptan Benzoate	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Hydrocortisone	Hydrocortisone	21	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	21
Ozempic	Semaglutide	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Famotidine	Famotidine	18	suppressed
Cefadroxil	Cefadroxil	17	16
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Scopolamine	Scopolamine	17	11
Baclofen	Baclofen	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ofloxacin	Ofloxacin	14	12
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Climara	Estradiol	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error